Shares of Gossamer Bio Inc. GOSS, -75.40% plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company’s experimental hypertension drug in a...
Tag: Drug
QURE Stock Rockets After FDA Approves Its Most Expensive Drug Ever
The Food and Drug Administration just approved its most expensive drug ever — a hemophilia B gene therapy from Carlisle Companies (CSL) and UniQure (QURE) — and QURE stock popped Wednesday. X Meanwhil...
New Lawsuit Aims To Revoke FDA Approval Of Abortion Drug
Topline Anti-abortion rights medical groups filed a federal lawsuit Friday seeking to overturn the government’s approval of abortion-inducing drugs mifepristone and misoprostol, potentially outlawing ...
After FDA Approval For Ovarian Cancer Drug, ImmunoGen Becomes Top Pick For This Analyst
Tuesday, the FDA granted accelerated approval for ImmunoGen Inc’s (NASDAQ: IMGN) Elahere (mirvetuximab soravtansine-gynx) for folate receptor alpha (FRα)-positive, platinum-resistant epithelial ...
Walmart Offers $3.1 Billion To Settle Opioid Lawsuits—Joining Rival Retailers Accused Of Fueling Drug Crisis
Topline Walmart on Tuesday offered to pay $3.1 billion to settle claims it mishandled prescriptions for powerful painkillers, joining a growing list of companies striking billion dollar deals to end r...
Mindfulness meditation reduces anxiety as much as common antidepressant drug: study
Mindfulness meditation is as effective at reducing anxiety as a commonly prescribed antidepressant, according to a study published in a major journal on Wednesday. The study, led by researchers at Geo...
APLS Stock Crashes On Unexpected Delay For Eye Drug, Dragging Iveric With It| Investor’s Business Daily
Apellis Pharmaceuticals (APLS) reported an unexpected delay for its eye-disease treatment, leading APLS stock to crash and taking shares of Iveric Bio (ISEE) with it. X Late Thursday, Apellis said it ...
AARP-Branded Medicare Drug Plan Is Too Costly for Many Retirees, Critics Say
The AARP name has become a marketing juggernaut among baby boomers, with the group’s nearly 38 million members receiving offers for AARP-branded health, life and auto insurance, and discounts on cellp...
Eli Lilly CEO on guidance cut, potential obesity drug, Alzheimer’s study
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report is...
3 Indian Crypto Exchanges on Investigators’ Radar for $3.5B Illegal Drug Transactions
Indian investigation agencies are probing three crypto exchanges for their roles in illegal drug trade transactions after they were alerted by the Financial Intelligence Unit (FIU), which has zeroed i...
Crypto Is Responsible for Spike in Drug Smuggling in India
Amit Shah, the Union Minister of India, said there is an increase in drug smuggling in India through crypto. Over 7% of the Indian population owns crypto. Amit Shah, the Union Minister of India said t...
GILD Stock: With A Breakout On The Line, Gilead Reports Massive Cancer Drug Sales
Gilead Sciences (GILD) crushed third-quarter expectations Thursday as sales of its cancer drugs nearly doubled. The results prodded GILD stock higher. X The bullish report follows recent approvals for...
2023 will be a ‘pivotal year’ as COVID-19 drug sales wane
Americans are moving on from COVID-19. Most public places, transit, and municipalities have gotten rid of mask mandates. Vaccine booster rates have plateaued, even with the introduction of a new “biva...
Indian Billionaire Pharma Brothers Get Boost From Their Go-To Pandemic Drug
This story appears in the October 2022 issue of Forbes Asia. Subscribe to Forbes Asia Dilip Surana Courtesy of Dilip Surana This story is part of Forbes’ coverage of India’s Richest 2022. See the full...
Dice Stock Touches Record High As Investors Eye Possible Best-In-Class Drug
Dice Therapeutics (DICE) stock skyrocketed Tuesday after the biotech company unveiled promising early-stage test results for a psoriasis pill. X On today’s stock market, shares of Dice stock soa...
California man indicted for laundering crypto in drug trafficking scheme
The Department of Justice announced charges against a California man Friday over allegedly attempting to launder drug trafficking proceeds through crypto channels. John Khuu allegedly distributed fake...
How One Scientist-Turned-Founder Is Bridging Drug Discovery With Blockchain
After years working in labs studying the cell cycle and the genetics of human disease, Gennaro D’Urso founded Genetic Networks, a for-profit company focused on drug discovery. As a teenager, D’U...
US DOJ charges man for using BTC to launder $5.4M in drug trafficking money
The U.S. Department of Justice (DOJ) has indicted California-based John Khuu for allegedly laundering $5.4 million in proceeds from drug trafficking by using Bitcoin. According to the charges, Khuu s...
Biogen Stock Explodes Higher After Alzheimer’s Drug Succeeds In Final-Phase Test
Biogen stock exploded higher Wednesday — bringing shares of other Alzheimer’s plays with it — after its experimental treatment succeeded in a final-phase test. X The results are sorely needed fo...
Biogen stock explodes higher after potential ‘mega blockbuster’ Alzheimer’s drug study
Biogen stock (BIIB) is booming amid as Wall Street speculates about a potential profit boom after a promising study detailed the company’s new Alzheimer’s drug in partnership with Japan’s ...
Biogen to pay $900 million to settle drug kickback allegations
A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen will pay $900 million to settle a lawsuit that alleged the company gave doctors kickbacks to encourage them prescribe its d...
CRSP Stock: The First CRISPR Gene-Editing Drug Could Be Here Sooner Than You Think
Crispr Therapeutics (CRSP) said Tuesday it will begin asking the Food and Drug Administration to approve what would be the first-ever gene-editing treatment to hit the market using the CRISPR technolo...
UBS upgrades Eli Lilly declaring LLY is working on ‘the biggest drug ever’
UBS Group (SWX: UBSG), a global financial provider, upgraded Eli Lilly (NYSE: LLY) to buy from neutral on Tuesday, September 20. UBS analyst Navin Jacob updated the price target from the previous $335...
‘Highly Compelling’ Eye Drug Data Has Wall Street Stampeding To Buy This ‘Large Cap Growth Story.’ Even After $15B In Market Cap Was Added
Reuters Videos Cineworld accesses $785 mln in financial aid STORY: Cinema chain Cineworld said on Friday (September 9) that a U.S. bankruptcy court has granted it access to around $785 million. That c...
Crypto Crimes at Rise in South Korea- 86 Individuals Arrested For Drug Trade
Join Our Telegram channel to stay up to date on breaking news coverage South Korea is no stranger to crypto crimes, and recent news has brought to light a dark-web-based drug trade- where the Gyeongbu...
178 Darkweb Users Arrested! Suspects of Darkweb Drug Dealings
Amid all the cybercrimes happening in the crypto ecosystem there’s a new splash directly from Seoul, South Korea. The police authorities have arrested 178 people on suspicion of drug dealing: buying, ...
Bernstein launches coverage of Canada’s Tilray, Cronos and Canopy Growth but stops short of any buy ratings
Sanford C. Bernstein & Co. analyst Nadine Sarwat initiated coverage of three Canadian cannabis stocks on Wednesday but stopped short of any buy recommendations at current levels. “Is the buzz gone...